UnknownNot Applicable

Effects of Xal-Ease on Patient Compliance With Xalatan

United States50 participantsStarted 2005-02

Plain-language summary

The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 40 to 80 years old * Diagnosis warranting treatment with Xalatan eye drops. * ambulatory and well functioning Exclusion Criteria: * non-ambulatory * less than 40 or greater than 80 years old * Not using Xalatan eye drops

What they're measuring

The primary outcome measure is compliance with the medication XALATAN using and not using the Xal-Ease delivery aid for their glaucoma treatment.

Timeframe: six months

Trial details

NCT IDNCT00573638

SponsorAugusta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Contact for this trial

Christian D. Nilson, MD

706-721-1150 cnilson@mail.mcg.edu

View on ClinicalTrials.gov More Glaucoma trials